AAAAI 2021: Dupilumab Enables Remission of Uncontrolled Asthma With Type 2 Inflammation
Exacerbations, symptom control, and lung function were all improved
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.